Official record
Measure details
- Jurisdiction
- Kentucky
- Session
- 2026RS
- Chamber
- lower
- Classification
- bill
- Subjects
- Administrative Regulations And Proceedings, Drugs And Medicines, Effective Dates, Emergency, Health And Medical Services, Health Care Professionals, Nurses, Opioids, Pharmacists, Physicians, Public Health, Substance Use
- Introduced / first action
- 2026-01-07 05:00:00
Source-supplied abstracts
Create a new section of KRS Chapter 13A to find 201 KAR 9:270 and 201 KAR 20:065 deficient and void; create new sections of KRS Chapters 311, 313, 314, and 315 to establish that the State Board of Medical Licensure, Board of Dentistry, Kentucky Board of Nursing, and Kentucky Board of Pharmacy shall not promulgate administrative regulations that restrict or limit the prescribing, dispensing, or administering of buprenorphine-mono-product, buprenorphine-combined-with-naloxone, or any other Schedule III, IV, or V medication approved by the United States Food and Drug Administration for the treatment of a substance use disorder; EMERGENCY.
Sponsors
- L. Willner (primary), primary
- C. Aull (primary), primary
- S. Bratcher (primary), primary
- B. Chester-Burton (primary), primary
- K. Fleming (primary), primary
- D. Grossberg (primary), primary
- V. Grossl (primary), primary
- C. Lewis (primary), primary
- K. Moser (primary), primary
- J. Nemes (primary), primary
- R. Roarx (primary), primary
- S. Stalker (primary), primary